A Look At The Intrinsic Value Of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Key Insights Recursion Pharmaceuticals' estimated fair value is US$14.64 based on 2 Stage Free Cash Flow to Equity...
United States Analysis For Recursion Pharmaceuticals Recursion Pharmaceuticals High Quality Alternatives Discounted Cash Flow Uture Cash Flows
Source: yahoo.com